(Q43732342)

26 November 2017

Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension (English)

1 reference

26 November 2017

R H Steinhorn

1

1 reference

26 November 2017

G Albert

2

1 reference

26 November 2017

D D Swartz

3

1 reference

26 November 2017

J A Russell

4

1 reference

26 November 2017

C R Levine

5

1 reference

26 November 2017

J M Davis

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

26 November 2017

1 reference

26 November 2017

164

1 reference

26 November 2017

834-839

1 reference

26 November 2017

5

1 reference

Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs

26 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

10.1164/AJRCCM.164.5.2010104

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference